trial · primary record
High intensity therapies
Acute Myeloid Leukemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 339 |
| Primary completion | 2028-01 |
| Primary endpoint | To determine in R/R AML patients the clinical benefit of low intensity therapy as shown by event-free survival compared to high intensity therapy. |
| Registry ID | NCT06713837 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:29.246Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06713837
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.